JMP Securities Believes Steris Corp (STE) Won’t Stop Here


JMP Securities analyst David Turkaly reiterated a Buy rating on Steris Corp (STE) yesterday and set a price target of $135. The company’s shares opened today at $120.54, close to its 52-week high of $123.50.

Turkaly said:

“We reiterate our Market Outperform rating on STERIS and price target of $135 following the release of F3Q19 results. STE announced quarterly results following Monday’s close, and will hold its call at 10 a.m. ET today; we will look for more color on guidance, as well as revenue and earnings drivers at that time. Our $135 price target is based on 23-24x our CY20 EPS estimate of $5.70. Our multiple reflects a slight discount to a group of mid-to-high single-digit growing, mid- cap MedTech peers.”

According to TipRanks.com, Turkaly is a 4-star analyst with an average return of 16.1% and a 55.7% success rate. Turkaly covers the Healthcare sector, focusing on stocks such as Apyx Medical Corporation, Haemonetics Corp, and Electrocore Llc.

Currently, the analyst consensus on Steris Corp is a Moderate Buy with an average price target of $130.50, representing an 8.3% upside. In a report released yesterday, Stephens also reiterated a Buy rating on the stock with a $135 price target.

See today’s analyst top recommended stocks >>

The company has a one-year high of $123.50 and a one-year low of $85.40. Currently, Steris Corp has an average volume of 452.5K.

Based on the recent corporate insider activity of 69 insiders, corporate insider sentiment is negative on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

STERIS Plc engages in the provision of infection prevention and other procedural products and services. It operates through the following segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts